Celularity Inc.
CELUHealthcare|Biotechnology|US
$0.76
+0.03 (+4.80%)
Cash / Share
$0.02
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Jan 8, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Oct 29, 2026 · Business Wire
Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement
Oct 22, 2026 · GlobeNewsWire
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
Sep 30, 2026 · GlobeNewsWire
Celularity Announces Naveen Jain to Join Board of Directors
Sep 29, 2026 · GlobeNewsWire
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
Sep 24, 2026 · GlobeNewsWire
Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform
Aug 27, 2026 · Business Wire
Celularity Provides Update Regarding Nasdaq Listing Compliance
Aug 25, 2026 · GlobeNewsWire
SEC Filings (89)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 29, 2026 | 8-K | Material event | DocumentIndex |
| Oct 29, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 20, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Oct 20, 2026 | 10-K/A | Annual report | DocumentIndex |
| Sep 29, 2026 | 8-K | Material event | DocumentIndex |
| Sep 29, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Sep 28, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 28, 2026 | 8-K | Material event | DocumentIndex |
| Sep 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | NT 10-Q | DocumentIndex | |
| Aug 7, 2026 | 8-K | Material event | DocumentIndex |
| Jul 29, 2026 | 8-K | Material event | DocumentIndex |
| Jul 22, 2026 | 25-NSE | DocumentIndex | |
| Jun 30, 2026 | 8-K | Material event | DocumentIndex |
| Jun 25, 2026 | 8-K | Material event | DocumentIndex |
| Jun 23, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jun 12, 2026 | 8-K | Material event | DocumentIndex |
| Jun 3, 2026 | 8-K | Material event | DocumentIndex |
| May 28, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | NT 10-Q | DocumentIndex | |
| Apr 30, 2026 | 10-K | Annual report | DocumentIndex |
| Apr 22, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Apr 21, 2026 | 8-K | Material event | DocumentIndex |
| Apr 3, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Mar 31, 2026 | NT 10-K | DocumentIndex | |
| Mar 10, 2026 | 8-K | Material event | DocumentIndex |
| Mar 5, 2026 | 8-K | Material event | DocumentIndex |
| Feb 11, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 21, 2026 | 8-K | Material event | DocumentIndex |
| Jan 8, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jan 7, 2026 | EFFECT | DocumentIndex | |
| Dec 31, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Dec 30, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Dec 29, 2025 | EFFECT | DocumentIndex | |
| Dec 23, 2025 | 8-K | Material event | DocumentIndex |
| Dec 19, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Dec 19, 2025 | 8-K | Material event | DocumentIndex |
| Dec 5, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 7, 2025 | S-8 | Employee stock plan | DocumentIndex |